business

Argenx stock price target held at $1,014 by Oppenheimer on myositis strategy

Investing.com · Jun 24, 2026, 11:31 AM · Also reported by 4 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Is Altimmune, Inc. (ALT) Still a Buy After Price Target Reduction to $20? Yahoo Finance Amgen Inc. (AMGN) Price Target Raised to $303 After Q1 Model Update Yahoo Finance When Strategy Will Need To Sell Bitcoin; MSTR Stock's Scary Math Yahoo Finance Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclays’ Target Increase?

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Argenx stock price target held at $1,014 by Oppenheimer on myositis strategy

Also covered by

More in business